Immune responses to respiratory syncytial virus (RSV) vaccines tended to fall short in older people with weakened immunity, a ...
Public health experts caution that the human metapneumovirus cases are part of the typical ebb and flow of respiratory virus ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...
Health officials are advising the immunocompromised to mask in public to prevent illness, and in Wisconsin, a major health ...
A Massachusetts mother is warning other parents about the respiratory risks this season as her young has been hospitalized ...
Approximately 40% of participants did not seroconvert or achieve a conservative neutralization threshold post-vaccination.
The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.
Recent reports from Malaysia reveal a 45% increase in human metapneumovirus (HMPV) cases in 2024 compared to 2023. The ...